APA (7th ed.) Citation

Martínez-Cáceres, E. M., Barrau, M. A., Brieva, L., Espejo, C., Barberà, N., & Montalban, X. (2002). Treatment with methylprednisolone in relapses of multiple sclerosis patients: Immunological evidence of immediate and short-term but not long-lasting effects. Clinical & Experimental Immunology, 127(1), 165. https://doi.org/10.1046/j.1365-2249.2002.01725.x

Chicago Style (17th ed.) Citation

Martínez-Cáceres, E. M., M. A. Barrau, L. Brieva, C. Espejo, N. Barberà, and X. Montalban. "Treatment with Methylprednisolone in Relapses of Multiple Sclerosis Patients: Immunological Evidence of Immediate and Short-term but Not Long-lasting Effects." Clinical & Experimental Immunology 127, no. 1 (2002): 165. https://doi.org/10.1046/j.1365-2249.2002.01725.x.

MLA (9th ed.) Citation

Martínez-Cáceres, E. M., et al. "Treatment with Methylprednisolone in Relapses of Multiple Sclerosis Patients: Immunological Evidence of Immediate and Short-term but Not Long-lasting Effects." Clinical & Experimental Immunology, vol. 127, no. 1, 2002, p. 165, https://doi.org/10.1046/j.1365-2249.2002.01725.x.